Biotech Acquisition Co (Biotech Acquisition Co) EV-to-FCF : -419.09 (As of May. 24, 2024)

Biotech Acquisition Co EV-to-FCF Chart

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-FCF	Get a 7-Day Free Trial				-242.10	-193.04	-403.25	-261.74	-409.60

Competitive Comparison of Biotech Acquisition Co's EV-to-FCF

For the Shell Companies subindustry, Biotech Acquisition Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Acquisition Co's EV-to-FCF Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's EV-to-FCF falls into.

Biotech Acquisition Co EV-to-FCF Calculation

Biotech Acquisition Co's EV-to-FCF for today is calculated as:

Biotech Acquisition Co's current Enterprise Value is $292.10 Mil.
Biotech Acquisition Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Acquisition Co  (NAS:BIOT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biotech Acquisition Co's PE Ratio for today is calculated as:

Biotech Acquisition Co's share price for today is $10.15.
Biotech Acquisition Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.255.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Biotech Acquisition Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description